Presymptomatic studies in genetic frontotemporal dementia

by Rohrer, J.D., Warren, J.D., Fox, N.C., Rossor, M.N.
Published 2013

Cerebral and cerebellar atrophy on serial magnetic resonance imaging in an initially symptom free subject at risk of familial prion disease.

by Fox, N. C., Freeborough, P. A., Mekkaoui, K. F., Stevens, J. M., Rossor, M. N.
Published 1997

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment

by Schott, J.M., Bartlett, J.W., Barnes, J., Leung, K.K., Ourselin, S., Fox, N.C.
Published 2010

Brain-water diffusion coefficients reflect the severity of inherited prion disease

by Hyare, H., Wroe, S., Siddique, D., Webb, T., Fox, N. C., Stevens, J., Collinge, J., Yousry, T., Thornton, J. S.
Published 2010

Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study

by Gordon, E., Rohrer, J. D., Kim, L. G., Omar, R., Rossor, M. N., Fox, N. C., Warren, J. D.
Published 2010

Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease

by Henley, S.M.D., Ridgway, G.R., Scahill, R.I., Klöppel, S., Tabrizi, S.J., Fox, N.C., Kassubek, J.
Published in AJNR Am J Neuroradiol (2010)

Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration

by Rohrer, J D., Warren, J D., Modat, M, Ridgway, G R., Douiri, A, Rossor, M N., Ourselin, S, Fox, N C.
Published 2009

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals

by Paterson, R W, Bartlett, J W, Blennow, K, Fox, N C, Shaw, L M, Trojanowski, J Q, Zetterberg, H, Schott, J M
Published 2014

Biomarkers in dementia: clinical utility and new directions

by Ahmed, R M, Paterson, R W, Warren, J D, Zetterberg, H, O'Brien, J T, Fox, N C, Halliday, G M, Schott, J M
Published in J Neurol Neurosurg Psychiatry (2014)

Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures

by Henneman, W J.P., Sluimer, J D., Barnes, J, van der Flier, W M., Sluimer, I C., Fox, N C., Scheltens, P, Vrenken, H, Barkhof, F
Published 2009

Operationalizing hippocampal volume as an enrichment biomarker for amnestic MCI trials: effect of algorithm, test-retest variability and cut-point on trial cost, duration and sampl...

by Yu, P., Sun, J., Wolz, R., Stephenson, D., Brewer, J., Fox, N.C., Cole, P.E., Jack, C.R., Hill, D.L.G., Schwarz, A.J.
Published 2013

Onset and Progression of Pathologic Atrophy in Huntington Disease: A Longitudinal MR Imaging Study

by Hobbs, N.Z., Barnes, J., Frost, C., Henley, S.M.D., Wild, E.J., Macdonald, K., Barker, R.A., Scahill, R.I., Fox, N.C., Tabrizi, S.J.
Published in AJNR Am J Neuroradiol (2010)

Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

by Henneman, W J.P., Vrenken, H, Barnes, J, Sluimer, I C., Verwey, N A., Blankenstein, M A., Klein, M, Fox, N C., Scheltens, P, Barkhof, F, van der Flier, W M.
Published 2009

Conversion of amyloid positive and negative MCI to AD over 3 years: An (11)C-PIB PET study

by Okello, A, Koivunen, J, Edison, P, Archer, H A., Turkheimer, F E., Någren, K, Bullock, R, Walker, Z, Kennedy, A, Fox, N C., Rossor, M N., Rinne, J O., Brooks, D J.
Published 2009

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

by Magdalinou, N K, Paterson, R W, Schott, J M, Fox, N C, Mummery, C, Blennow, K, Bhatia, K, Morris, H R, Giunti, P, Warner, T T, de Silva, R, Lees, A J, Zetterberg, H
Published in J Neurol Neurosurg Psychiatry (2015)

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology

by Paterson, R W, Heywood, W E, Heslegrave, A J, Magdalinou, N K, Andreasson, U, Sirka, E, Bliss, E, Slattery, C F, Toombs, J, Svensson, J, Johansson, P, Fox, N C, Zetterberg, H, Mills, K, Schott, J M
Published in Transl Psychiatry (2016)

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

by Salloway, S, Sperling, R, Gilman, S, Fox, N C., Blennow, K, Raskind, M, Sabbagh, M, Honig, L S., Doody, R, van Dyck, C H., Mulnard, R, Barakos, J, Gregg, K M., Liu, E, Lieberburg, I, Schenk, D, Black, R, Grundman, M
Published 2009

Magnetization Transfer Ratio in Alzheimer Disease: Comparison with Volumetric Measurements

by Ridha, B.H., Symms, M.R., Tozer, D.J., Stockton, K.C., Frost, C., Siddique, M.M., Lewis, E.B., MacManus, D.G., Boulby, P.A., Barker, G.J., Rossor, M.N., Fox, N.C., Tofts, P.S.
Published in AJNR Am J Neuroradiol (2007)

The heritability and genetics of frontotemporal lobar degeneration

by Rohrer, J D., Guerreiro, R, Vandrovcova, J, Uphill, J, Reiman, D, Beck, J, Isaacs, A M., Authier, A, Ferrari, R, Fox, N C., Mackenzie, I R.A., Warren, J D., de Silva, R, Holton, J, Revesz, T, Hardy, J, Mead, S, Rossor, M N.
Published 2009

Impact of APOE4-CSF Aβ interaction on hippocampal volume loss over 1 year in MCI

by Chiang, G.C., Insel, P.S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S.T., Thompson, P.M., Reiman, E.M., Jack, C.R., Fox, N.C., Jagust, W.J., Harvey, D.J., Beckett, L.A., Gamst, A., Aisen, P.S., Petersen, R.C., Weiner, M.W.
Published 2011